Group 1: Research Basic Information - The research object is Lier Chemical, belonging to the pesticide and veterinary medicine industry, and the reception time is May 22, 2025. The listed company's reception staff includes Deputy General Manager and Board Secretary Liu Jun, and Liu Yu from the Board Office [16] Group 2: Detailed Research Institutions - The research institutions include securities companies such as Everbright Securities, Tianfeng Securities, Orient Securities, and CITIC Construction Investment; asset management companies like Ruijun Asset and Taikang Asset; fund management companies including Penghyang Fund, Invesco Great Wall, and Huatai-PineBridge Fund; and investment companies such as Hezhong Yisheng and Zhongrui Heyin [17][18] Group 3: Proportion of Research Institutions - Securities companies account for 36%, asset management companies 7%, fund management companies 36%, and investment companies 14% [20] Group 4: Main Content Information - The company's Q1 2025 performance rebounded due to increased sales and prices of some products and effective cost - reduction and efficiency - improvement measures. Some peer companies also had good Q1 performance, indicating improved supply - demand for some pesticide products, but the overall industry trend still needs close observation [23] - As the price of glufosinate - ammonium technical gradually declines, the market demand and the company's sales volume are increasing. However, the industry competition is still fierce, and the price is at a historical low [24] - The company is optimistic about the market space of refined glufosinate - ammonium. As more enterprises obtain product registrations, promote the market, and improve production technology, market demand will continue to grow. The company, as the largest domestic producer of refined glufosinate - ammonium technical, will accelerate overseas registration and market layout [26] - In 2024, the company's international sales accounted for 47%, with exports to over thirty countries and regions including the US. The company's main technical products were on the exemption list during the previous US "reciprocal tariff" policy, and recent Sino - US tariff policy adjustments have little short - term impact on the company [27] - The company is not currently considering an incentive plan [28] - The acquisition of Shandong Huimeng is in the due - diligence and demonstration process [29] - The change of the company's controlling shareholder and actual controller is based on the notice from Jiuyuan Group. The progress needs to go through a series of operations and state - owned asset approval processes, and the company believes it will promote further development [30][31]
利尔化学分析师会议-20250522